Zacks Investment Research upgraded EndoChoice from a “hold” rating to a “buy” rating.
SpectraScience acquired the assets of Oncoscope.
Mauna Kea Technologies enrolled more than 200 patients in its CONTACT II clinical study.
Miraca Life Sciences launched the EoGenius test, which helps diagnose and monitor patients with eosinophilic esophagitis.
More articles on GI/endoscopy:
GI physician leader to know: Dr. Neena Abraham of Mayo Clinic
5 most read GI/endoscopy stories: Week of Feb. 29 – March 4
St. Francis Regional, Ridgeview medical centers come together for GI care: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
